CD4 and neoplasm: Khalique et al [4] also found significantly higher numbers of immunosuppressive subpopulations (TAMs and FOXP3+/CD4+ regulatory T‐cells) in the stroma relative to tumours of patients with improved outcomes, suggesting that the ‘tumour‐exclusion’ of these cells is important in maintaining an effective anti‐tumour immune response.